Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Ketamine by Neurocentrx Pharma for Bipolar Disorder (Manic Depression): Likelihood of Approval
Ketamine is under clinical development by Neurocentrx Pharma and currently in Phase I for Bipolar Disorder (Manic Depression). According to...